RYBELSUS® is contraindicated in patients with a personal or family heritage of MTC As well as in clients with Various Endocrine Neoplasia syndrome type two (MEN two). Counsel clients concerning the probable risk for MTC with using RYBELSUS® and tell them of indicators of thyroid tumors (e. Su médico le https://weightlosspharmaceutic.com/product/rybelsus-semaglutide-3mg-tablets/